TY - JOUR AU - McGuire, S. PY - 2016 DA - 2016// TI - World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015 JO - Adv Nutr VL - 7 UR - https://doi.org/10.3945/an.116.012211 DO - 10.3945/an.116.012211 ID - McGuire2016 ER - TY - JOUR AU - Bogdanove, A. J. AU - Voytas, D. F. PY - 2011 DA - 2011// TI - TAL effectors: customizable proteins for DNA targeting JO - Science VL - 333 UR - https://doi.org/10.1126/science.1204094 DO - 10.1126/science.1204094 ID - Bogdanove2011 ER - TY - JOUR AU - Stoddard, B. L. PY - 2005 DA - 2005// TI - Homing endonuclease structure and function JO - Q Rev Biophys VL - 38 UR - https://doi.org/10.1017/S0033583505004063 DO - 10.1017/S0033583505004063 ID - Stoddard2005 ER - TY - JOUR AU - Urnov, F. D. PY - 2010 DA - 2010// TI - Genome editing with engineered zinc finger nucleases JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2842 DO - 10.1038/nrg2842 ID - Urnov2010 ER - TY - JOUR AU - Sharan, S. K. PY - 2009 DA - 2009// TI - Recombineering: a homologous recombination-based method of genetic engineering JO - Nat Protoc VL - 4 UR - https://doi.org/10.1038/nprot.2008.227 DO - 10.1038/nprot.2008.227 ID - Sharan2009 ER - TY - JOUR AU - Kato-Inui, T. PY - 2018 DA - 2018// TI - Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 with improved proof-reading enhances homology-directed repair JO - Nucleic Acids Res VL - 46 UR - https://doi.org/10.1093/nar/gky264 DO - 10.1093/nar/gky264 ID - Kato-Inui2018 ER - TY - JOUR AU - Doudna, J. A. AU - Charpentier, E. PY - 2014 DA - 2014// TI - Genome editing. The new frontier of genome engineering with CRISPR–Cas9 JO - Science VL - 346 UR - https://doi.org/10.1126/science.1258096 DO - 10.1126/science.1258096 ID - Doudna2014 ER - TY - JOUR AU - Brouns, S. J. PY - 2008 DA - 2008// TI - Small CRISPR RNAs guide antiviral defense in prokaryotes JO - Science VL - 321 UR - https://doi.org/10.1126/science.1159689 DO - 10.1126/science.1159689 ID - Brouns2008 ER - TY - JOUR AU - Oost, J. PY - 2009 DA - 2009// TI - CRISPR-based adaptive and heritable immunity in prokaryotes JO - Trends Biochem Sci VL - 34 UR - https://doi.org/10.1016/j.tibs.2009.05.002 DO - 10.1016/j.tibs.2009.05.002 ID - Oost2009 ER - TY - JOUR AU - Sternberg, S. H. PY - 2014 DA - 2014// TI - DNA interrogation by the CRISPR RNA-guided endonuclease Cas9 JO - Nature VL - 507 UR - https://doi.org/10.1038/nature13011 DO - 10.1038/nature13011 ID - Sternberg2014 ER - TY - JOUR AU - Porteus, M. H. AU - Baltimore, D. PY - 2003 DA - 2003// TI - Chimeric nucleases stimulate gene targeting in human cells JO - Science VL - 300 UR - https://doi.org/10.1126/science.1078395 DO - 10.1126/science.1078395 ID - Porteus2003 ER - TY - JOUR AU - Miller, J. C. PY - 2007 DA - 2007// TI - An improved zinc-finger nuclease architecture for highly specific genome editing JO - Nat Biotechnol VL - 25 UR - https://doi.org/10.1038/nbt1319 DO - 10.1038/nbt1319 ID - Miller2007 ER - TY - JOUR AU - Sander, J. D. PY - 2011 DA - 2011// TI - Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA) JO - Nat Methods VL - 8 UR - https://doi.org/10.1038/nmeth.1542 DO - 10.1038/nmeth.1542 ID - Sander2011 ER - TY - JOUR AU - Wood, A. J. PY - 2011 DA - 2011// TI - Targeted genome editing across species using ZFNs and TALENs JO - Science VL - 333 UR - https://doi.org/10.1126/science.1207773 DO - 10.1126/science.1207773 ID - Wood2011 ER - TY - JOUR AU - Christian, M. PY - 2010 DA - 2010// TI - Targeting DNA double-strand breaks with TAL effector nucleases JO - Genetics VL - 186 UR - https://doi.org/10.1534/genetics.110.120717 DO - 10.1534/genetics.110.120717 ID - Christian2010 ER - TY - JOUR AU - Zhang, F. PY - 2011 DA - 2011// TI - Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription JO - Nat Biotechnol VL - 29 UR - https://doi.org/10.1038/nbt.1775 DO - 10.1038/nbt.1775 ID - Zhang2011 ER - TY - JOUR AU - Reyon, D. PY - 2012 DA - 2012// TI - FLASH assembly of TALENs for high-throughput genome editing JO - Nat Biotechnol VL - 30 UR - https://doi.org/10.1038/nbt.2170 DO - 10.1038/nbt.2170 ID - Reyon2012 ER - TY - JOUR AU - Boch, J. PY - 2009 DA - 2009// TI - Breaking the code of DNA binding specificity of TAL-type III effectors JO - Science VL - 326 UR - https://doi.org/10.1126/science.1178811 DO - 10.1126/science.1178811 ID - Boch2009 ER - TY - JOUR AU - Moscou, M. J. AU - Bogdanove, A. J. PY - 2009 DA - 2009// TI - A simple cipher governs DNA recognition by TAL effectors JO - Science VL - 326 UR - https://doi.org/10.1126/science.1178817 DO - 10.1126/science.1178817 ID - Moscou2009 ER - TY - JOUR AU - Sanjana, N. E. PY - 2012 DA - 2012// TI - A transcription activator-like effector toolbox for genome engineering JO - Nat Protoc VL - 7 UR - https://doi.org/10.1038/nprot.2011.431 DO - 10.1038/nprot.2011.431 ID - Sanjana2012 ER - TY - JOUR AU - Hockemeyer, D. PY - 2011 DA - 2011// TI - Genetic engineering of human pluripotent cells using TALE nucleases JO - Nat Biotechnol VL - 29 UR - https://doi.org/10.1038/nbt.1927 DO - 10.1038/nbt.1927 ID - Hockemeyer2011 ER - TY - JOUR AU - Gasiunas, G. PY - 2012 DA - 2012// TI - Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria JO - Proc Natl Acad Sci USA VL - 109 UR - https://doi.org/10.1073/pnas.1208507109 DO - 10.1073/pnas.1208507109 ID - Gasiunas2012 ER - TY - JOUR AU - Garneau, J. E. PY - 2010 DA - 2010// TI - The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA JO - Nature VL - 468 UR - https://doi.org/10.1038/nature09523 DO - 10.1038/nature09523 ID - Garneau2010 ER - TY - JOUR AU - Bothmer, A. PY - 2017 DA - 2017// TI - Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms13905 DO - 10.1038/ncomms13905 ID - Bothmer2017 ER - TY - JOUR AU - Bhattacharjee, S. AU - Nandi, S. PY - 2016 DA - 2016// TI - Choices have consequences: the nexus between DNA repair pathways and genomic instability in cancer JO - Clin Transl Med VL - 5 UR - https://doi.org/10.1186/s40169-016-0128-z DO - 10.1186/s40169-016-0128-z ID - Bhattacharjee2016 ER - TY - JOUR AU - Bhattacharjee, S. AU - Nandi, S. PY - 2017 DA - 2017// TI - Synthetic lethality in DNA repair network: a novel avenue in targeted cancer therapy and combination therapeutics JO - IUBMB Life VL - 69 UR - https://doi.org/10.1002/iub.1696 DO - 10.1002/iub.1696 ID - Bhattacharjee2017 ER - TY - JOUR AU - Bhattacharjee, S. AU - Nandi, S. PY - 2017 DA - 2017// TI - DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway JO - Cell Commun Signal VL - 15 UR - https://doi.org/10.1186/s12964-017-0195-9 DO - 10.1186/s12964-017-0195-9 ID - Bhattacharjee2017 ER - TY - JOUR AU - Bhattacharjee, S. AU - Nandi, S. PY - 2018 DA - 2018// TI - Rare genetic diseases with defects in dna repair: opportunities and challenges in orphan drug development for targeted cancer therapy JO - Cancer VL - 10 UR - https://doi.org/10.3390/cancers10090298 DO - 10.3390/cancers10090298 ID - Bhattacharjee2018 ER - TY - JOUR AU - Castel, S. E. PY - 2014 DA - 2014// TI - Dicer promotes transcription termination at sites of replication stress to maintain genome stability JO - Cell VL - 159 UR - https://doi.org/10.1016/j.cell.2014.09.031 DO - 10.1016/j.cell.2014.09.031 ID - Castel2014 ER - TY - JOUR AU - Perez, E. E. PY - 2008 DA - 2008// TI - Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases JO - Nat Biotechnol VL - 26 UR - https://doi.org/10.1038/nbt1410 DO - 10.1038/nbt1410 ID - Perez2008 ER - TY - JOUR AU - Chen, F. PY - 2011 DA - 2011// TI - High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases JO - Nat Methods VL - 8 UR - https://doi.org/10.1038/nmeth.1653 DO - 10.1038/nmeth.1653 ID - Chen2011 ER - TY - JOUR AU - Cong, L. PY - 2013 DA - 2013// TI - Multiplex genome engineering using CRISPR/Cas systems JO - Science VL - 339 UR - https://doi.org/10.1126/science.1231143 DO - 10.1126/science.1231143 ID - Cong2013 ER - TY - JOUR AU - Song, F. AU - Stieger, K. PY - 2017 DA - 2017// TI - Optimizing the DNA donor template for homology-directed repair of double-strand breaks JO - Mol Ther Nucleic Acids VL - 7 UR - https://doi.org/10.1016/j.omtn.2017.02.006 DO - 10.1016/j.omtn.2017.02.006 ID - Song2017 ER - TY - JOUR AU - Adli, M. PY - 2018 DA - 2018// TI - The CRISPR tool kit for genome editing and beyond JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-04252-2 DO - 10.1038/s41467-018-04252-2 ID - Adli2018 ER - TY - JOUR AU - Rath, D. PY - 2015 DA - 2015// TI - The CRISPR–Cas immune system: biology, mechanisms and applications JO - Biochimie VL - 117 UR - https://doi.org/10.1016/j.biochi.2015.03.025 DO - 10.1016/j.biochi.2015.03.025 ID - Rath2015 ER - TY - JOUR AU - Marraffini, L. A. AU - Sontheimer, E. J. PY - 2008 DA - 2008// TI - CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA JO - Science VL - 322 UR - https://doi.org/10.1126/science.1165771 DO - 10.1126/science.1165771 ID - Marraffini2008 ER - TY - JOUR AU - Barrangou, R. PY - 2007 DA - 2007// TI - CRISPR provides acquired resistance against viruses in prokaryotes JO - Science VL - 315 UR - https://doi.org/10.1126/science.1138140 DO - 10.1126/science.1138140 ID - Barrangou2007 ER - TY - JOUR AU - Shmakov, S. PY - 2017 DA - 2017// TI - Diversity and evolution of class 2 CRISPR–Cas systems JO - Nat Rev Microbiol VL - 15 UR - https://doi.org/10.1038/nrmicro.2016.184 DO - 10.1038/nrmicro.2016.184 ID - Shmakov2017 ER - TY - JOUR AU - Nishimasu, H. PY - 2017 DA - 2017// TI - Structural basis for the altered PAM recognition by engineered CRISPR–Cpf1 JO - Mol Cell VL - 67 UR - https://doi.org/10.1016/j.molcel.2017.04.019 DO - 10.1016/j.molcel.2017.04.019 ID - Nishimasu2017 ER - TY - JOUR AU - Makarova, K. S. PY - 2015 DA - 2015// TI - An updated evolutionary classification of CRISPR–Cas systems JO - Nat Rev Microbiol VL - 13 UR - https://doi.org/10.1038/nrmicro3569 DO - 10.1038/nrmicro3569 ID - Makarova2015 ER - TY - JOUR AU - Yamano, T. PY - 2017 DA - 2017// TI - Structural basis for the canonical and non-canonical PAM recognition by CRISPR–Cpf1 JO - Mol Cell VL - 67 UR - https://doi.org/10.1016/j.molcel.2017.06.035 DO - 10.1016/j.molcel.2017.06.035 ID - Yamano2017 ER - TY - JOUR AU - Khan, A. O. PY - 2017 DA - 2017// TI - CRISPR–Cas9 mediated labelling allows for single molecule imaging and resolution JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-08493-x DO - 10.1038/s41598-017-08493-x ID - Khan2017 ER - TY - JOUR AU - Jinek, M. PY - 2012 DA - 2012// TI - A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity JO - Science VL - 337 UR - https://doi.org/10.1126/science.1225829 DO - 10.1126/science.1225829 ID - Jinek2012 ER - TY - JOUR AU - Komor, A. C. PY - 2016 DA - 2016// TI - Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage JO - Nature VL - 533 UR - https://doi.org/10.1038/nature17946 DO - 10.1038/nature17946 ID - Komor2016 ER - TY - JOUR AU - Barrangou, R. AU - Doudna, J. A. PY - 2016 DA - 2016// TI - Applications of CRISPR technologies in research and beyond JO - Nat Biotechnol VL - 34 UR - https://doi.org/10.1038/nbt.3659 DO - 10.1038/nbt.3659 ID - Barrangou2016 ER - TY - JOUR AU - Zetsche, B. PY - 2015 DA - 2015// TI - Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR–Cas system JO - Cell VL - 163 UR - https://doi.org/10.1016/j.cell.2015.09.038 DO - 10.1016/j.cell.2015.09.038 ID - Zetsche2015 ER - TY - JOUR AU - Deltcheva, E. PY - 2011 DA - 2011// TI - CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III JO - Nature VL - 471 UR - https://doi.org/10.1038/nature09886 DO - 10.1038/nature09886 ID - Deltcheva2011 ER - TY - JOUR AU - Fonfara, I. PY - 2014 DA - 2014// TI - Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR–Cas systems JO - Nucleic Acids Res VL - 42 UR - https://doi.org/10.1093/nar/gkt1074 DO - 10.1093/nar/gkt1074 ID - Fonfara2014 ER - TY - JOUR AU - Karvelis, T. PY - 2015 DA - 2015// TI - Rapid characterization of CRISPR–Cas9 protospacer adjacent motif sequence elements JO - Genome Biol VL - 16 UR - https://doi.org/10.1186/s13059-015-0818-7 DO - 10.1186/s13059-015-0818-7 ID - Karvelis2015 ER - TY - JOUR AU - Ran, F. A. PY - 2015 DA - 2015// TI - In vivo genome editing using Staphylococcus aureus Cas9 JO - Nature VL - 520 UR - https://doi.org/10.1038/nature14299 DO - 10.1038/nature14299 ID - Ran2015 ER - TY - JOUR AU - Kim, D. PY - 2016 DA - 2016// TI - Genome-wide target specificities of CRISPR–Cas9 nucleases revealed by multiplex Digenome-seq JO - Genome Res VL - 26 UR - https://doi.org/10.1101/gr.199588.115 DO - 10.1101/gr.199588.115 ID - Kim2016 ER - TY - JOUR AU - Kleinstiver, B. P. PY - 2016 DA - 2016// TI - High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects JO - Nature VL - 529 UR - https://doi.org/10.1038/nature16526 DO - 10.1038/nature16526 ID - Kleinstiver2016 ER - TY - JOUR AU - Fonfara, I. PY - 2016 DA - 2016// TI - The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA JO - Nature VL - 532 UR - https://doi.org/10.1038/nature17945 DO - 10.1038/nature17945 ID - Fonfara2016 ER - TY - JOUR AU - Abudayyeh, O. O. PY - 2017 DA - 2017// TI - RNA targeting with CRISPR–Cas13 JO - Nature VL - 550 UR - https://doi.org/10.1038/nature24049 DO - 10.1038/nature24049 ID - Abudayyeh2017 ER - TY - JOUR AU - Smargon, A. A. PY - 2017 DA - 2017// TI - Cas13b is a type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28 JO - Mol Cell VL - 65 UR - https://doi.org/10.1016/j.molcel.2016.12.023 DO - 10.1016/j.molcel.2016.12.023 ID - Smargon2017 ER - TY - JOUR AU - Qi, L. S. PY - 2013 DA - 2013// TI - Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression JO - Cell VL - 152 UR - https://doi.org/10.1016/j.cell.2013.02.022 DO - 10.1016/j.cell.2013.02.022 ID - Qi2013 ER - TY - JOUR AU - Gilbert, L. A. PY - 2013 DA - 2013// TI - CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes JO - Cell VL - 154 UR - https://doi.org/10.1016/j.cell.2013.06.044 DO - 10.1016/j.cell.2013.06.044 ID - Gilbert2013 ER - TY - JOUR AU - Mali, P. PY - 2013 DA - 2013// TI - RNA-guided human genome engineering via Cas9 JO - Science VL - 339 UR - https://doi.org/10.1126/science.1232033 DO - 10.1126/science.1232033 ID - Mali2013 ER - TY - JOUR AU - Tanenbaum, M. E. PY - 2014 DA - 2014// TI - A protein-tagging system for signal amplification in gene expression and fluorescence imaging JO - Cell VL - 159 UR - https://doi.org/10.1016/j.cell.2014.09.039 DO - 10.1016/j.cell.2014.09.039 ID - Tanenbaum2014 ER - TY - JOUR AU - Konermann, S. PY - 2015 DA - 2015// TI - Genome-scale transcriptional activation by an engineered CRISPR–Cas9 complex JO - Nature VL - 517 UR - https://doi.org/10.1038/nature14136 DO - 10.1038/nature14136 ID - Konermann2015 ER - TY - JOUR AU - Zalatan, J. G. PY - 2015 DA - 2015// TI - Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds JO - Cell VL - 160 UR - https://doi.org/10.1016/j.cell.2014.11.052 DO - 10.1016/j.cell.2014.11.052 ID - Zalatan2015 ER - TY - JOUR AU - Miles, L. A. AU - Garippa, R. J. AU - Poirier, J. T. PY - 2016 DA - 2016// TI - Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens JO - FEBS J VL - 283 UR - https://doi.org/10.1111/febs.13770 DO - 10.1111/febs.13770 ID - Miles2016 ER - TY - JOUR AU - Fellmann, C. PY - 2011 DA - 2011// TI - Functional identification of optimized RNAi triggers using a massively parallel sensor assay JO - Mol Cell VL - 41 UR - https://doi.org/10.1016/j.molcel.2011.02.008 DO - 10.1016/j.molcel.2011.02.008 ID - Fellmann2011 ER - TY - JOUR AU - Bassik, M. C. PY - 2009 DA - 2009// TI - Rapid creation and quantitative monitoring of high coverage shRNA libraries JO - Nat Methods VL - 6 UR - https://doi.org/10.1038/nmeth.1330 DO - 10.1038/nmeth.1330 ID - Bassik2009 ER - TY - JOUR AU - Knott, S. R. V. PY - 2014 DA - 2014// TI - A computational algorithm to predict shRNA potency JO - Mol Cell VL - 56 UR - https://doi.org/10.1016/j.molcel.2014.10.025 DO - 10.1016/j.molcel.2014.10.025 ID - Knott2014 ER - TY - JOUR AU - Carette, J. E. PY - 2009 DA - 2009// TI - Haploid genetic screens in human cells identify host factors used by pathogens JO - Science VL - 326 UR - https://doi.org/10.1126/science.1178955 DO - 10.1126/science.1178955 ID - Carette2009 ER - TY - JOUR AU - Collaboration, O. R. PY - 2016 DA - 2016// TI - The ORFeome Collaboration: a genome-scale human ORF-clone resource JO - Nat Methods VL - 13 UR - https://doi.org/10.1038/nmeth.3776 DO - 10.1038/nmeth.3776 ID - Collaboration2016 ER - TY - JOUR AU - Wang, T. PY - 2014 DA - 2014// TI - Genetic screens in human cells using the CRISPR–Cas9 system JO - Science VL - 343 UR - https://doi.org/10.1126/science.1246981 DO - 10.1126/science.1246981 ID - Wang2014 ER - TY - JOUR AU - Shalem, O. PY - 2014 DA - 2014// TI - Genome-scale CRISPR–Cas9 knockout screening in human cells JO - Science VL - 343 UR - https://doi.org/10.1126/science.1247005 DO - 10.1126/science.1247005 ID - Shalem2014 ER - TY - JOUR AU - Hou, P. PY - 2017 DA - 2017// TI - A genome-wide CRISPR screen identifies genes critical for resistance to FLT3 inhibitor AC220 JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-1627 DO - 10.1158/0008-5472.CAN-16-1627 ID - Hou2017 ER - TY - JOUR AU - Ruiz, S. PY - 2016 DA - 2016// TI - A genome-wide CRISPR screen identifies CDC25A as a determinant of sensitivity to ATR inhibitors JO - Mol Cell VL - 62 UR - https://doi.org/10.1016/j.molcel.2016.03.006 DO - 10.1016/j.molcel.2016.03.006 ID - Ruiz2016 ER - TY - JOUR AU - Sanjana, N. E. PY - 2016 DA - 2016// TI - High-resolution interrogation of functional elements in the noncoding genome JO - Science VL - 353 UR - https://doi.org/10.1126/science.aaf7613 DO - 10.1126/science.aaf7613 ID - Sanjana2016 ER - TY - JOUR AU - Shen, J. P. PY - 2017 DA - 2017// TI - Combinatorial CRISPR–Cas9 screens for de novo mapping of genetic interactions JO - Nat Methods VL - 14 UR - https://doi.org/10.1038/nmeth.4225 DO - 10.1038/nmeth.4225 ID - Shen2017 ER - TY - JOUR AU - Han, K. PY - 2017 DA - 2017// TI - Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions JO - Nat Biotechnol VL - 35 UR - https://doi.org/10.1038/nbt.3834 DO - 10.1038/nbt.3834 ID - Han2017 ER - TY - JOUR AU - Burr, M. L. PY - 2017 DA - 2017// TI - CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity JO - Nature VL - 549 UR - https://doi.org/10.1038/nature23643 DO - 10.1038/nature23643 ID - Burr2017 ER - TY - JOUR AU - Hart, T. PY - 2015 DA - 2015// TI - High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities JO - Cell VL - 163 UR - https://doi.org/10.1016/j.cell.2015.11.015 DO - 10.1016/j.cell.2015.11.015 ID - Hart2015 ER - TY - JOUR AU - Wang, T. PY - 2015 DA - 2015// TI - Identification and characterization of essential genes in the human genome JO - Science VL - 350 UR - https://doi.org/10.1126/science.aac7041 DO - 10.1126/science.aac7041 ID - Wang2015 ER - TY - JOUR AU - Shi, J. PY - 2015 DA - 2015// TI - Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death JO - Nature VL - 526 UR - https://doi.org/10.1038/nature15514 DO - 10.1038/nature15514 ID - Shi2015 ER - TY - JOUR AU - Luo, J. PY - 2016 DA - 2016// TI - CRISPR/Cas9: from genome engineering to cancer drug discovery JO - Trends Cancer VL - 2 UR - https://doi.org/10.1016/j.trecan.2016.05.001 DO - 10.1016/j.trecan.2016.05.001 ID - Luo2016 ER - TY - JOUR AU - Gilbert, L. A. PY - 2014 DA - 2014// TI - Genome-scale CRISPR-mediated control of gene repression and activation JO - Cell VL - 159 UR - https://doi.org/10.1016/j.cell.2014.09.029 DO - 10.1016/j.cell.2014.09.029 ID - Gilbert2014 ER - TY - JOUR AU - Quail, D. F. AU - Joyce, J. A. PY - 2013 DA - 2013// TI - Microenvironmental regulation of tumor progression and metastasis JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3394 DO - 10.1038/nm.3394 ID - Quail2013 ER - TY - JOUR AU - Chen, S. PY - 2015 DA - 2015// TI - Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis JO - Cell VL - 160 UR - https://doi.org/10.1016/j.cell.2015.02.038 DO - 10.1016/j.cell.2015.02.038 ID - Chen2015 ER - TY - JOUR AU - Zhan, T. PY - 2018 DA - 2018// TI - CRISPR/Cas9 for cancer research and therapy JO - Semin Cancer Biol UR - https://doi.org/10.1016/j.semcancer.2018.04.001 DO - 10.1016/j.semcancer.2018.04.001 ID - Zhan2018 ER - TY - JOUR AU - Katigbak, A. PY - 2016 DA - 2016// TI - A CRISPR/Cas9 functional screen identifies rare tumor suppressors JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep38968 DO - 10.1038/srep38968 ID - Katigbak2016 ER - TY - JOUR AU - Manguso, R. T. PY - 2017 DA - 2017// TI - In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target JO - Nature VL - 547 UR - https://doi.org/10.1038/nature23270 DO - 10.1038/nature23270 ID - Manguso2017 ER - TY - JOUR AU - Patel, S. J. PY - 2017 DA - 2017// TI - Identification of essential genes for cancer immunotherapy JO - Nature VL - 548 UR - https://doi.org/10.1038/nature23477 DO - 10.1038/nature23477 ID - Patel2017 ER - TY - JOUR AU - Yau, E. H. PY - 2017 DA - 2017// TI - Genome-wide CRISPR screen for essential cell growth mediators in mutant KRAS colorectal cancers JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-17-2043 DO - 10.1158/0008-5472.CAN-17-2043 ID - Yau2017 ER - TY - JOUR AU - Braun, C. J. PY - 2016 DA - 2016// TI - Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation JO - Proc Natl Acad Sci USA VL - 113 UR - https://doi.org/10.1073/pnas.1600582113 DO - 10.1073/pnas.1600582113 ID - Braun2016 ER - TY - JOUR AU - Kodama, M. PY - 2017 DA - 2017// TI - In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer JO - Proc Natl Acad Sci USA VL - 114 UR - https://doi.org/10.1073/pnas.1705441114 DO - 10.1073/pnas.1705441114 ID - Kodama2017 ER - TY - JOUR AU - Chow, R. D. AU - Chen, S. PY - 2018 DA - 2018// TI - Cancer CRISPR screens in vivo JO - Trends Cancer VL - 4 UR - https://doi.org/10.1016/j.trecan.2018.03.002 DO - 10.1016/j.trecan.2018.03.002 ID - Chow2018 ER - TY - JOUR AU - Burgess, D. J. PY - 2015 DA - 2015// TI - Cancer genetics: cRISPR screens go in vivo JO - Nat Rev Genet VL - 16 ID - Burgess2015 ER - TY - JOUR AU - Xue, W. PY - 2014 DA - 2014// TI - CRISPR-mediated direct mutation of cancer genes in the mouse liver JO - Nature VL - 514 UR - https://doi.org/10.1038/nature13589 DO - 10.1038/nature13589 ID - Xue2014 ER - TY - JOUR AU - Sanchez-Rivera, F. J. PY - 2014 DA - 2014// TI - Rapid modelling of cooperating genetic events in cancer through somatic genome editing JO - Nature VL - 516 UR - https://doi.org/10.1038/nature13906 DO - 10.1038/nature13906 ID - Sanchez-Rivera2014 ER - TY - JOUR AU - Swiech, L. PY - 2015 DA - 2015// TI - In vivo interrogation of gene function in the mammalian brain using CRISPR–Cas9 JO - Nat Biotechnol VL - 33 UR - https://doi.org/10.1038/nbt.3055 DO - 10.1038/nbt.3055 ID - Swiech2015 ER - TY - JOUR AU - Weber, J. PY - 2015 DA - 2015// TI - CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice JO - Proc Natl Acad Sci USA VL - 112 UR - https://doi.org/10.1073/pnas.1512392112 DO - 10.1073/pnas.1512392112 ID - Weber2015 ER - TY - JOUR AU - Ghosh, D. AU - Nandi, S. AU - Bhattacharjee, S. PY - 2018 DA - 2018// TI - Combination therapy to checkmate glioblastoma: clinical challenges and advances JO - Clin Transl Med VL - 7 UR - https://doi.org/10.1186/s40169-018-0211-8 DO - 10.1186/s40169-018-0211-8 ID - Ghosh2018 ER - TY - JOUR AU - Zhou, Q. PY - 2015 DA - 2015// TI - A chemical genetics approach for the functional assessment of novel cancer genes JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2930 DO - 10.1158/0008-5472.CAN-14-2930 ID - Zhou2015 ER - TY - JOUR AU - Choi, P. S. AU - Meyerson, M. PY - 2014 DA - 2014// TI - Targeted genomic rearrangements using CRISPR/Cas technology JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4728 DO - 10.1038/ncomms4728 ID - Choi2014 ER - TY - JOUR AU - Torres, R. PY - 2014 DA - 2014// TI - Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4964 DO - 10.1038/ncomms4964 ID - Torres2014 ER - TY - JOUR AU - Yamauchi, T. PY - 2018 DA - 2018// TI - Genome-wide CRISPR–Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS JO - Cancer Cell VL - 33 UR - https://doi.org/10.1016/j.ccell.2018.01.012 DO - 10.1016/j.ccell.2018.01.012 ID - Yamauchi2018 ER - TY - JOUR AU - Wang, H. AU - Sun, W. PY - 2017 DA - 2017// TI - CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation JO - Cancer Lett VL - 385 UR - https://doi.org/10.1016/j.canlet.2016.10.033 DO - 10.1016/j.canlet.2016.10.033 ID - Wang2017 ER - TY - JOUR AU - Baliou, S. PY - 2018 DA - 2018// TI - CRISPR therapeutic tools for complex genetic disorders and cancer (review) JO - Int J Oncol VL - 53 ID - Baliou2018 ER - TY - JOUR AU - Matano, M. PY - 2015 DA - 2015// TI - Modeling colorectal cancer using CRISPR–Cas9-mediated engineering of human intestinal organoids JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3802 DO - 10.1038/nm.3802 ID - Matano2015 ER - TY - JOUR AU - Drost, J. PY - 2017 DA - 2017// TI - Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer JO - Science VL - 358 UR - https://doi.org/10.1126/science.aao3130 DO - 10.1126/science.aao3130 ID - Drost2017 ER - TY - JOUR AU - Seino, T. PY - 2018 DA - 2018// TI - Human pancreatic tumor organoids reveal loss of stem cell Niche factor dependence during disease progression JO - Cell Stem Cell VL - 22 UR - https://doi.org/10.1016/j.stem.2017.12.009 DO - 10.1016/j.stem.2017.12.009 ID - Seino2018 ER - TY - JOUR AU - Wang, H. PY - 2013 DA - 2013// TI - One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering JO - Cell VL - 153 UR - https://doi.org/10.1016/j.cell.2013.04.025 DO - 10.1016/j.cell.2013.04.025 ID - Wang2013 ER - TY - JOUR AU - Maddalo, D. PY - 2014 DA - 2014// TI - In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system JO - Nature VL - 516 UR - https://doi.org/10.1038/nature13902 DO - 10.1038/nature13902 ID - Maddalo2014 ER - TY - JOUR AU - Blasco, R. B. PY - 2014 DA - 2014// TI - Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology JO - Cell Rep VL - 9 UR - https://doi.org/10.1016/j.celrep.2014.10.051 DO - 10.1016/j.celrep.2014.10.051 ID - Blasco2014 ER - TY - JOUR AU - Platt, R. J. PY - 2014 DA - 2014// TI - CRISPR–Cas9 knockin mice for genome editing and cancer modeling JO - Cell VL - 159 UR - https://doi.org/10.1016/j.cell.2014.09.014 DO - 10.1016/j.cell.2014.09.014 ID - Platt2014 ER - TY - JOUR AU - Annunziato, S. PY - 2016 DA - 2016// TI - Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland JO - Genes Dev VL - 30 UR - https://doi.org/10.1101/gad.279190.116 DO - 10.1101/gad.279190.116 ID - Annunziato2016 ER - TY - JOUR AU - Lee, Y. C. PY - 2018 DA - 2018// TI - Impact of detergents on membrane protein complex isolation JO - J Proteome Res VL - 17 UR - https://doi.org/10.1021/acs.jproteome.7b00599 DO - 10.1021/acs.jproteome.7b00599 ID - Lee2018 ER - TY - JOUR AU - Snook, A. E. AU - Waldman, S. A. PY - 2013 DA - 2013// TI - Advances in cancer immunotherapy JO - Discov Med VL - 15 ID - Snook2013 ER - TY - JOUR AU - Topalian, S. L. PY - 2016 DA - 2016// TI - Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.36 DO - 10.1038/nrc.2016.36 ID - Topalian2016 ER - TY - JOUR AU - Mellman, I. AU - Coukos, G. AU - Dranoff, G. PY - 2011 DA - 2011// TI - Cancer immunotherapy comes of age JO - Nature VL - 480 UR - https://doi.org/10.1038/nature10673 DO - 10.1038/nature10673 ID - Mellman2011 ER - TY - JOUR AU - Kalos, M. PY - 2011 DA - 2011// TI - T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3002842 DO - 10.1126/scitranslmed.3002842 ID - Kalos2011 ER - TY - JOUR AU - Hinrichs, C. S. AU - Rosenberg, S. A. PY - 2014 DA - 2014// TI - Exploiting the curative potential of adoptive T-cell therapy for cancer JO - Immunol Rev VL - 257 UR - https://doi.org/10.1111/imr.12132 DO - 10.1111/imr.12132 ID - Hinrichs2014 ER - TY - JOUR AU - Rosenberg, S. A. AU - Restifo, N. P. PY - 2015 DA - 2015// TI - Adoptive cell transfer as personalized immunotherapy for human cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa4967 DO - 10.1126/science.aaa4967 ID - Rosenberg2015 ER - TY - JOUR AU - June, C. H. AU - Riddell, S. R. AU - Schumacher, T. N. PY - 2015 DA - 2015// TI - Adoptive cellular therapy: a race to the finish line JO - Sci Transl Med VL - 7 UR - https://doi.org/10.1126/scitranslmed.aaa3643 DO - 10.1126/scitranslmed.aaa3643 ID - June2015 ER - TY - JOUR AU - Maus, M. V. PY - 2014 DA - 2014// TI - Antibody-modified T cells: CARs take the front seat for hematologic malignancies JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-11-492231 DO - 10.1182/blood-2013-11-492231 ID - Maus2014 ER - TY - JOUR AU - Brudno, J. N. PY - 2018 DA - 2018// TI - T cells genetically modified to express an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2018.77.8084 DO - 10.1200/JCO.2018.77.8084 ID - Brudno2018 ER - TY - JOUR AU - Xia, A. L. PY - 2017 DA - 2017// TI - Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.19361 DO - 10.18632/oncotarget.19361 ID - Xia2017 ER - TY - JOUR AU - Neelapu, S. S. AU - Locke, F. L. AU - Go, W. Y. PY - 2018 DA - 2018// TI - CAR T-cell therapy in large B-cell lymphoma JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMc1800913 DO - 10.1056/NEJMc1800913 ID - Neelapu2018 ER - TY - JOUR AU - Lee, D. W. PY - 2015 DA - 2015// TI - T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61403-3 DO - 10.1016/S0140-6736(14)61403-3 ID - Lee2015 ER - TY - JOUR AU - Park, J. H. AU - Geyer, M. B. AU - Brentjens, R. J. PY - 2016 DA - 2016// TI - CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2016-02-629063 DO - 10.1182/blood-2016-02-629063 ID - Park2016 ER - TY - JOUR AU - Wei, S. C. AU - Duffy, C. R. AU - Allison, J. P. PY - 2018 DA - 2018// TI - Fundamental mechanisms of immune checkpoint blockade therapy JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-18-0367 DO - 10.1158/2159-8290.CD-18-0367 ID - Wei2018 ER - TY - JOUR AU - Fesnak, A. D. AU - June, C. H. AU - Levine, B. L. PY - 2016 DA - 2016// TI - Engineered T cells: the promise and challenges of cancer immunotherapy JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.97 DO - 10.1038/nrc.2016.97 ID - Fesnak2016 ER - TY - JOUR AU - Ren, J. PY - 2017 DA - 2017// TI - A versatile system for rapid multiplex genome-edited CAR T cell generation JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.15218 DO - 10.18632/oncotarget.15218 ID - Ren2017 ER - TY - JOUR AU - Eyquem, J. PY - 2017 DA - 2017// TI - Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection JO - Nature VL - 543 UR - https://doi.org/10.1038/nature21405 DO - 10.1038/nature21405 ID - Eyquem2017 ER - TY - JOUR AU - Su, S. PY - 2016 DA - 2016// TI - CRISPR–Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep20070 DO - 10.1038/srep20070 ID - Su2016 ER - TY - JOUR AU - Lloyd, A. AU - Vickery, O. N. AU - Laugel, B. PY - 2013 DA - 2013// TI - Beyond the antigen receptor: editing the genome of T-cells for cancer adoptive cellular therapies JO - Front Immunol VL - 4 UR - https://doi.org/10.3389/fimmu.2013.00221 DO - 10.3389/fimmu.2013.00221 ID - Lloyd2013 ER - TY - JOUR AU - Cyranoski, D. PY - 2016 DA - 2016// TI - CRISPR gene-editing tested in a person for the first time JO - Nature VL - 539 UR - https://doi.org/10.1038/nature.2016.20988 DO - 10.1038/nature.2016.20988 ID - Cyranoski2016 ER - TY - JOUR AU - Zhang, C. PY - 2017 DA - 2017// TI - Engineering CAR-T cells JO - Biomarkers Res VL - 5 UR - https://doi.org/10.1186/s40364-017-0102-y DO - 10.1186/s40364-017-0102-y ID - Zhang2017 ER - TY - JOUR AU - Zhang, X. H. PY - 2015 DA - 2015// TI - Off-target effects in CRISPR/Cas9-mediated genome engineering JO - Mol Ther Nucleic Acids VL - 4 UR - https://doi.org/10.1038/mtna.2015.37 DO - 10.1038/mtna.2015.37 ID - Zhang2015 ER - TY - JOUR AU - Cho, S. W. PY - 2014 DA - 2014// TI - Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases JO - Genome Res VL - 24 UR - https://doi.org/10.1101/gr.162339.113 DO - 10.1101/gr.162339.113 ID - Cho2014 ER - TY - JOUR AU - Wu, X. AU - Kriz, A. J. AU - Sharp, P. A. PY - 2014 DA - 2014// TI - Target specificity of the CRISPR–Cas9 system JO - Quant Biol VL - 2 UR - https://doi.org/10.1007/s40484-014-0030-x DO - 10.1007/s40484-014-0030-x ID - Wu2014 ER - TY - JOUR AU - Clarke, R. PY - 2018 DA - 2018// TI - Enhanced bacterial immunity and mammalian genome editing via RNA-polymerase-mediated dislodging of Cas9 from double-strand DNA breaks JO - Mol Cell VL - 71 UR - https://doi.org/10.1016/j.molcel.2018.06.005 DO - 10.1016/j.molcel.2018.06.005 ID - Clarke2018 ER - TY - STD TI - Charlesworth CT, et al. Identification of pre-existing adaptive immunity to Cas9 proteins in humans. 2018. ID - ref137 ER - TY - JOUR AU - Kosicki, M. AU - Tomberg, K. AU - Bradley, A. PY - 2018 DA - 2018// TI - Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements JO - Nat Biotechnol VL - 36 ID - Kosicki2018 ER - TY - JOUR AU - Hsu, P. D. PY - 2013 DA - 2013// TI - DNA targeting specificity of RNA-guided Cas9 nucleases JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2647 DO - 10.1038/nbt.2647 ID - Hsu2013 ER - TY - JOUR AU - Pattanayak, V. PY - 2013 DA - 2013// TI - High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2673 DO - 10.1038/nbt.2673 ID - Pattanayak2013 ER - TY - JOUR AU - Fu, Y. PY - 2013 DA - 2013// TI - High-frequency off-target mutagenesis induced by CRISPR–Cas nucleases in human cells JO - Nat Biotechnol VL - 31 UR - https://doi.org/10.1038/nbt.2623 DO - 10.1038/nbt.2623 ID - Fu2013 ER - TY - JOUR AU - Kunne, T. PY - 2016 DA - 2016// TI - Cas3-derived target DNA degradation fragments fuel primed CRISPR adaptation JO - Mol Cell VL - 63 UR - https://doi.org/10.1016/j.molcel.2016.07.011 DO - 10.1016/j.molcel.2016.07.011 ID - Kunne2016 ER - TY - JOUR AU - Rouillon, C. PY - 2018 DA - 2018// TI - Control of cyclic oligoadenylate synthesis in a type III CRISPR system JO - Elife UR - https://doi.org/10.7554/eLife.36734 DO - 10.7554/eLife.36734 ID - Rouillon2018 ER - TY - JOUR AU - Wright, A. V. AU - Nunez, J. K. AU - Doudna, D. o. u. d. n. a. PY - 2016 DA - 2016// TI - Biology and applications of CRISPR systems: Harnessing nature's toolbox for genome engineering JO - Cell VL - 164 UR - https://doi.org/10.1016/j.cell.2015.12.035 DO - 10.1016/j.cell.2015.12.035 ID - Wright2016 ER - TY - JOUR AU - Abudayyeh, O. O. PY - 2016 DA - 2016// TI - C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector JO - Science VL - 353 UR - https://doi.org/10.1126/science.aaf5573 DO - 10.1126/science.aaf5573 ID - Abudayyeh2016 ER -